KRAS and colorectal carcinoma: Studies analyzing mutant KRAS CRC found that solute carrier family 25 member 22 (SLC25A22) promoted proliferation and migration of human CRC tumor cells which also resulted in the developments of metastases in CRC xenograft mouse models (Wong et al., 2016).